GI Permeability Change in Response to Aquamin® | MicrobiomeTrials← Back to trialsNCT04855799
GI Permeability Change in Response to Aquamin®
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2021-11-02Est. Completion: 2024-03-11
Enrollment target: 35 participants Locations- University of Michigan Hospital, Ann Arbor, Michigan, United States
Other microbiome trials you might be interested in
Ulcerative Colitis
The purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-a…
New York, United StatesEst. completion Jun 23, 2027
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Recruiting
Ulcerative ColitisCrohn's Disease
More older people (more than 65 years of age) around the world are getting Ulcerative Colitis (UC) or Crohn's Disease (C…
Cambridge, United StatesEst. completion Dec 15, 2026